Literature DB >> 27660671

Systemic hemodynamics in advanced cirrhosis: Concerns during perioperative period of liver transplantation.

Tomohide Hori1, Yasuhiro Ogura1, Yasuharu Onishi1, Hideya Kamei1, Nobuhiko Kurata1, Motoshi Kainuma1, Hideo Takahashi1, Shogo Suzuki1, Takashi Ichikawa1, Shoko Mizuno1, Tadashi Aoyama1, Yuki Ishida1, Takahiro Hirai1, Tomoko Hayashi1, Kazuko Hasegawa1, Hiromu Takeichi1, Atsunobu Ota1, Yasuhiro Kodera1, Hiroyuki Sugimoto1, Taku Iida1, Shintaro Yagi1, Kentaro Taniguchi1, Shinji Uemoto1.   

Abstract

Advanced liver cirrhosis is usually accompanied by portal hypertension. Long-term portal hypertension results in various vascular alterations. The systemic hemodynamic state in patients with cirrhosis is termed a hyperdynamic state. This peculiar hemodynamic state is characterized by an expanded blood volume, high cardiac output, and low total peripheral resistance. Vascular alterations do not disappear even long after liver transplantation (LT), and recipients with cirrhosis exhibit a persistent systemic hyperdynamic state even after LT. Stability of optimal systemic hemodynamics is indispensable for adequate portal venous flow (PVF) and successful LT, and reliable parameters for optimal systemic hemodynamics and adequate PVF are required. Even a subtle disorder in systemic hemodynamics is precisely indicated by the balance between cardiac output and blood volume. The indocyanine green (ICG) kinetics reflect the patient's functional hepatocytes and effective PVF, and PVF is a major determinant of the ICG elimination constant (kICG) in the well-preserved allograft. The kICG value is useful to set the optimal PVF during living-donor LT and to evaluate adequate PVF after LT. Perioperative management has a large influence on the postoperative course and outcome; therefore, key points and unexpected pitfalls for intensive management are herein summarized. Transplant physicians should fully understand the peculiar systemic hemodynamic behavior in LT recipients with cirrhosis and recognize the critical importance of PVF after LT.

Entities:  

Keywords:  Hyperdynamic; Indocyanine green; Liver cirrhosis; Liver transplantation; Portal hypertension

Year:  2016        PMID: 27660671      PMCID: PMC5026996          DOI: 10.4254/wjh.v8.i25.1047

Source DB:  PubMed          Journal:  World J Hepatol


  126 in total

1.  Simultaneous measurement of effective hepatic blood flow and systemic circulation.

Authors:  M Hashimoto; G Watanabe
Journal:  Hepatogastroenterology       Date:  2000 Nov-Dec

2.  Circulatory changes in chronic liver disease.

Authors:  J F MURRAY; A M DAWSON; S SHERLOCK
Journal:  Am J Med       Date:  1958-03       Impact factor: 4.965

3.  High cardiac output of advanced liver disease persists after orthotopic liver transplantation.

Authors:  J M Henderson; G J Mackay; M Hooks; J L Chezmar; J R Galloway; T F Dodson; M H Kutner
Journal:  Hepatology       Date:  1992-02       Impact factor: 17.425

4.  How transplant surgeons can overcome the inevitable insufficiency of allograft size during adult living-donor liver transplantation: strategy for donor safety with a smaller-size graft and excellent recipient results.

Authors:  Tomohide Hori; Yasuhiro Ogura; Kohei Ogawa; Toshimi Kaido; Hajime Segawa; Hideaki Okajima; Takayuki Kogure; Shinji Uemoto
Journal:  Clin Transplant       Date:  2012 May-Jun       Impact factor: 2.863

5.  Comparison of cardiac output and circulatory blood volumes by transpulmonary thermo-dye dilution and transcutaneous indocyanine green measurement in critically ill patients.

Authors:  Samir G Sakka; Konrad Reinhart; Karl Wegscheider; Andreas Meier-Hellmann
Journal:  Chest       Date:  2002-02       Impact factor: 9.410

6.  Clinical applications of ICG Finger Monitor in patients with liver disease.

Authors:  Y Ishigami; M Masuzawa; E Miyoshi; M Kato; K Tamura; M Kanda; K Awazu; K Taniguchi; M Kurita; N Hayashi
Journal:  J Hepatol       Date:  1993-09       Impact factor: 25.083

7.  Determination of blood volume using indocyanine green (cardio-green) dye.

Authors:  E C Bradley; J W Barr
Journal:  Life Sci       Date:  1968-09-01       Impact factor: 5.037

8.  Circulating blood volume measured by pulse dye-densitometry: comparison with (131)I-HSA analysis.

Authors:  T Iijima; Y Iwao; H Sankawa
Journal:  Anesthesiology       Date:  1998-12       Impact factor: 7.892

9.  Liver transplantation in highest acuity recipients: identifying factors to avoid futility.

Authors:  Henrik Petrowsky; Abbas Rana; Fady M Kaldas; Anuj Sharma; Johnny C Hong; Vatche G Agopian; Francisco Durazo; Henry Honda; Jeffrey Gornbein; Victor Wu; Douglas G Farmer; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2014-06       Impact factor: 12.969

10.  Hemodynamics after orthotopic liver transplantation: study of associated factors and long-term effects.

Authors:  A Gadano; A Hadengue; J J Widmann; F Vachiery; R Moreau; S Yang; T Soupison; P Sogni; C Degott; F Durand
Journal:  Hepatology       Date:  1995-08       Impact factor: 17.425

View more
  5 in total

1.  Effect of direct-acting antivirals on corrected QT interval and cardiac functions in patients with chronic hepatitis C virus infection.

Authors:  Mohamed Gamal Ibrahim; Ahmed Abdelrahman Sharafeldin; Nevine Ibrahim Mousa; Tarek Khairy Mousa; Ahmed Mohamed El Missiri
Journal:  Egypt Heart J       Date:  2020-02-07

2.  Invasive hemodynamic parameters in patients with hepatorenal syndrome.

Authors:  Jerald Pelayo; Kevin Bryan Lo; Sahar Sultan; Eduardo Quintero; Eric Peterson; Grace Salacupa; Martin Angelo Zanoria; Geneva Guarin; Beth Helfman; Julien Sanon; Roy Mathew; Ali Yazdanyar; Victor Navarro; Gregg Pressman; Janani Rangaswami
Journal:  Int J Cardiol Heart Vasc       Date:  2022-08-11

Review 3.  Hepatic Encephalopathy: From Metabolic to Neurodegenerative.

Authors:  Rafael Ochoa-Sanchez; Farzaneh Tamnanloo; Christopher F Rose
Journal:  Neurochem Res       Date:  2021-06-15       Impact factor: 3.996

4.  Intentional Modulation of Portal Venous Pressure by Splenectomy Saves the Patient with Liver Failure and Portal Hypertension After Major Hepatectomy: Is Delayed Splenectomy an Acceptable Therapeutic Option for Secondary Portal Hypertension?

Authors:  Yuichi Takamatsu; Tomohide Hori; Takafumi Machimoto; Toshiyuki Hata; Yoshio Kadokawa; Tatsuo Ito; Shigeru Kato; Daiki Yasukawa; Yuki Aisu; Yusuke Kimura; Taku Kitano; Tsunehiro Yoshimura
Journal:  Am J Case Rep       Date:  2018-02-07

5.  Indocyanine green fluorescence angiography during liver and pancreas transplantation: a tool to integrate perfusion statement's evaluation.

Authors:  Fabrizio Panaro; Enrico Benedetti; Guillaume Pineton de Chambrun; Hussein Habibeh; Piera Leon; Hassan Bouyabrine; Astrid Herrero; Francis Navarro
Journal:  Hepatobiliary Surg Nutr       Date:  2018-06       Impact factor: 7.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.